(Updated - July 27, 2020 5:02 AM EDT)(updating comment)Morgan Stanley analyst Matthew Harrison upgraded Biogen (NASDAQ: BIIB) from Underweight to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE